Table 6. Relationships between LINC00152 transcript and TB-related drug adverse responses.

Drug adverse reactions	LINC00152 levels	P
Anemia n (%)		0.348
Presence (73, 15.33)	9.63 (3.52−13.72)
Absence (403, 84.67)	7.56 (3.69−17.63)
Leukopenia n (%)		0.769
Presence (80, 16.80)	7.20 (3.91−14.80)
Absence (396, 83.20)	7.56 (3.55−15.97)
Thrombocytopenia n (%)		0.775
Presence (31, 6.51)	6.72 (2.87−30.01)
Absence (445, 93.49)	7.56 (3.73−15.22)
Drug-induced hepatotoxicity n (%)		0.602
Presence (73, 15.33)	6.35 (3.56−15.06)
Absence (403, 84.67)	7.61 (3.65−15.70)
Chronic kidney damage n (%)		0.419
Presence (7, 1.47)	5.40 (3.45−12.42)
Absence (469, 98.53)	7.50 (3.60−15.81)